Sangamo Announces Preliminary Results From the First Three Patients in a Phase 1/2 Study Evaluating ST-400 Ex Vivo Gene-edited Cell Therapy in Beta Thalassemia
First three patients experienced prompt hematopoietic reconstitution, and no clonal hematopoiesis Early first-in-human data provide insights into relationship between product…